Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
May 13, 2020
| Craig Burton
AAM Supports Updating Medicare to Lower Costs for America’s Seniors
Blog
May 13, 2020
| Bob Billings
Thank You, Bill Haddad
Blog
Mar 30, 2020
| Jeff Francer
COVID-19: This Week’s Initiatives From the Generic and Biosimilars Industry
Blog
Mar 19, 2020
| Jeff Francer
AAM’s COVID-19 Response: Helping Patients and Families Meet Their Health Care Needs
Blog
Feb 28, 2020
| Jeff Francer
AAM Interim CEO Jeff Francer on COVID-19
Blog
Feb 28, 2020
| Erica Klinger
Stories and Data: How AAM Equips Advocates in the States
Blog
Feb 27, 2020
| Erik Komendant
The First (Price) Cut Is the Steepest
Blog
Feb 25, 2020
| Sara Skubikowski
Savings by Condition: The Latest Data
Blog
Jan 9, 2020
| Karin Hessler
Competition Matters. That’s Why We Need to Further Improve IPR.
Blog
Dec 18, 2019
| Kristin Murphy
Women-Powered Health Policy: 500 and Counting
Blog
Nov 19, 2019
| Jonathan Kimball
Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA
Blog
Nov 18, 2019
| Erica Klinger
Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action